EUVIMEDEUVIMED entdecken
Crossref

Factor VIII, a coagulation cofactor, is a relevant survival factor in bladder cancer cell lines

Gillian E Walker, Ester Borroni, Rida Haider, Cristina Olgasi, Chiara Borsotti, Antonia Follenzi

Journal of Thrombosis and Haemostasis · 2025-11 · 23 (11) · 3466-3480

DOI: 10.1016/j.jtha.2025.03.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-11. Verfasst von Gillian E Walker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Histology Laboratory, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Factor VIII. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Compagnia di San Paolo, Conseil Supérieur de la Pêche, Fondazione Telethon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Factor (F)VIII, an essential coagulation cofactor and independent cancer-associated thrombotic risk factor, has recently been shown to be synthesized directly by a broad profile of cancers. With evident extracoagulative functions, it remains to be understood if FVIII can play a functional role in cancer. OBJECTIVES: Establish if FVIII plays a direct role in bladder cancer cell models. METHODS: Bladder cancer cell lines 5637 and ECV-304 were treated with recombinant human FVIII (rFVIII) B-domain-deleted or full-length rFVIII (rFVIII-FL) in low serum conditions, where cell cycle, migration, and cell survival were assessed. Cell cycle was measured by 7-aminoactinomycin D incorporation and migration by Transwell or wound healing assays. Cell survival was assessed by crystal violet (optical density 592) and 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide (optical density 570) assays. Cell adhesion was determined with integrin β1 and αV protein levels, annexin-V-FITC/7-aminoactinomycin D staining, and Bcl2 with procaspase3 levels for apoptosis. Cancer cell-derived effects were assessed by silencing FVIII using short hairpin RNA. RESULTS: In both bladder cancer cell lines, cell cycle progression was pushed, and migration was advanced by rFVIII. More dramatic were the survival effects for rFVIII-FL, confirmed in a cell line of diverse origin, the osteosarcoma U2OS, through the maintenance of cell adhesion and inhibition of apoptosis. Further, silencing cell-derived FVIII retarded both cell cycle progression and migration. More importantly, cell survival was dramatically reduced and could be blocked by the administration of rFVIII-FL. CONCLUSION: Overall, this investigation highlights FVIII as a relevant survival factor in bladder cancer cells and provides evidence of its role in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsFactor VIIIHumansCell Line, TumorCell SurvivalCell MovementApoptosisCell AdhesionCell CycleRecombinant ProteinsCaspase 3Proto-Oncogene Proteins c-bcl-2

Stichwörter der Autor:innen

apoptosisbladder cancercell survivalfactor VIIIintegrins

Substanzen

Factor VIIIF8 protein, humanRecombinant ProteinsCaspase 3BCL2 protein, humanProto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Histology Laboratory, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
  • Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
  • Histology Laboratory, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy; Department of Integrated Activities and Research Innovation, Azienda Ospedaliero-Universitaria di Alessandria, Aless…

Förderung

  • Compagnia di San Paolo
  • Conseil Supérieur de la Pêche
  • Fondazione Telethon

Zitieren

APA

Walker, G. E., Borroni, E., Haider, R., Olgasi, C., Borsotti, C., & Follenzi, A. (2025). Factor VIII, a coagulation cofactor, is a relevant survival factor in bladder cancer cell lines. Journal of Thrombosis and Haemostasis, 23(11), 3466-3480. https://doi.org/10.1016/j.jtha.2025.03.002

Vancouver

Walker GE, Borroni E, Haider R, Olgasi C, Borsotti C, Follenzi A. Factor VIII, a coagulation cofactor, is a relevant survival factor in bladder cancer cell lines. Journal of Thrombosis and Haemostasis. 2025;23(11):3466-3480. doi:10.1016/j.jtha.2025.03.002

BibTeX
@article{Walker2025,
  author = {Walker, Gillian E and Borroni, Ester and Haider, Rida and Olgasi, Cristina and Borsotti, Chiara and Follenzi, Antonia},
  title = {Factor VIII, a coagulation cofactor, is a relevant survival factor in bladder cancer cell lines},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {11},
  pages = {3466--3480},
  doi = {10.1016/j.jtha.2025.03.002}
}
Kostenlos starten →